SBIR/STTR Research Award

Novel preservation fluid for organ transplantation

Award identifier d9dbf5d271b2adcb1dfa03e34da67c7cc6a366673c685a57c81f2415864c6ddfAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$183,523

Program and phase

SBIR · Phase I

Award year

2003

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
Inotek Pharmaceuticals Corporation
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): Nitric oxide and peroxynitrite are reactive, short-lived species that are important mediators of various forms of hypoxia - reperfusion injury. One of the dow5nstream pathways of peroxynitrite-mediated organ injury is related to activation of the nuclear enzyme poly (ADP-ribose) synthetase (PARS). Based on in vitro and in vivo preliminary data, the applicants propose that the PARS pathway may play a role in the pathogenesis of the reperfusion injury associated with the transplantation of hypoxic organs, and propose studies to directly test the hypothesis that PARP inhibition supplementation in the organ storage fluid is able to improve the function of the transplanted organ. The first aim of the current project is to establish time course of PARS activation and associated organ dysfunction in an experimental kidney transplantation model, and to correlate these alterations with reactive nitrogen species formation in the organ. Reactive nitrogen species formation and PARS activation will be investigated using immunohistochemistry, and organ function will be investigated using conventional techniques. The second aim of the project is to perform direct studies into the role of PARS-related transplantation-induced kidney dysfunction. We will compare traditional organ preservation fluids with ones spiked with a novel potent PARS inhibitor, followed by evaluation of changes in the kidney function associated with transplantation. We will also evaluate the effect of treatment of the recipient with PARS inhibitor. Our studies will provide novel mechanistic information on ischemic storage and transplantation-related renal dysfunction which will be utilized for the future design and commercial development of novel organ preservation fluids.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.